EMEA-001324-PIP01-12-M01
Key facts
Active substance |
glibenclamide
|
Therapeutic area |
Other
|
Decision number |
P/0072/2015
|
PIP number |
EMEA-001324-PIP01-12-M01
|
Pharmaceutical form(s) |
Oral suspension
|
Condition(s) / indication(s) |
Treatment of neonatal diabetes mellitus
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
AMMTeK
|
Decision type |
PM: decision on the application for modification of an agreed PIP
|